Clinical Trials Browser

Phase 2 × Small Cell Lung Cancer Extensive Stage × camrelizumab × Clear all

NCT03755115 2019-01-16

SHR-1210 Combined With Epirubicin in the Treatment of Extensive Disease Small Cell Lung Cancer

Phase 2 Unknown

Small Cell Lung Cancer Extensive Stage